1. OAR@UM
  2. Faculty of Medicine and Surgery
  3. Department of Pharmacy
  4. Scholarly Works - FacM&SPha
Please use this identifier to cite or link to this item: https://www.um.edu.mt/library/oar/handle/123456789/48853
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2019-11-21T15:01:11Z-
dc.date.available2019-11-21T15:01:11Z-
dc.date.issued2018-10-
dc.identifier.citationSadaf, S., Mifsud Buhagiar, L., Attard Pizzuto, M., & Serracino-Inglott, A. (2018, October). Accessibility and safety of antipsychotics in the treatment of autism spectrum disorder in children and adolescents. Poster session presented at the ACCP Global Conference on Clinical Pharmacy, Seattle, Washington, USA.en_GB
dc.identifier.urihttps://www.um.edu.mt/library/oar/handle/123456789/48853-
dc.description.abstractA poster presentation regarding the accessibility and safety of antipsychotics in the treatment of autism spectrum disorder in children and adolescents. Introduction: Risperidone and aripiprazole (RiAr) are antipsychotic drugs approved by the Food and Drug Administration (FDA) for the management of irritability associated with Autism Spectrum Disorder (ASD) in children and adolescents. Cultural, regulatory and economic differences in countries like India and Malta may affect the prescribing behaviour of these drugs in ASD. Aims: To study prescribing behaviour, safety and accessibility of RiAr in children and adolescents in India and Malta.en_GB
dc.language.isoenen_GB
dc.publisherUniversity of Malta. Department of Pharmacyen_GB
dc.rightsinfo:eu-repo/semantics/openAccessen_GB
dc.subjectAutism spectrum disorders -- Treatmenten_GB
dc.subjectRisperidoneen_GB
dc.subjectAripiprazoleen_GB
dc.subjectAutism spectrum disorders -- Malta -- Case studiesen_GB
dc.subjectAutism spectrum disorders -- India -- Case studiesen_GB
dc.subjectAutism spectrum disorders -- Comparative studiesen_GB
dc.subjectChildhood Autism Rating Scaleen_GB
dc.subjectAntipsychotic drugsen_GB
dc.titleAccessibility and safety of antipsychotics in the treatment of autism spectrum disorder in children and adolescentsen_GB
dc.typepresentationen_GB
dc.rights.holderThe copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder.en_GB
dc.description.reviewedN/Aen_GB
dc.contributor.creatorSadaf, Shaista-
dc.contributor.creatorMifsud Buhagiar, Luana-
dc.contributor.creatorAttard Pizzuto, Maresca-
dc.contributor.creatorSerracino-Inglott, Anthony-
Appears in Collections:Scholarly Works - FacM&SPha

Files in This Item:
File Description SizeFormat 
Accessibility_and_safety_of_antipsychotics_in_the_treatment_of_autism_spectrum_disorder_in _children_and_adolescents_2018.pdf524.7 kBAdobe PDFView/Open
Show simple item record Statistics


Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.